T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Penske Automotive Group
PAG
$14.4B
| $751K | ﹤0.01% |
9,354
+4,052
| +76% | +$283K |
|
|
MIME
2177
DELISTED
Mimecast Limited
MIME
| $748K | ﹤0.01% |
18,608
+1,055
| +6% | +$46.5K |
|
2178
Crinetics Pharmaceuticals
CRNX
$8.96B
| $747K | ﹤0.01% |
48,865
-32,037
| -40% | -$497K |
|
2179
Invesco Mortgage Capital
IVR
$805M
| $743K | ﹤0.01% |
18,523
+3,223
| +21% | +$122K |
|
|
CATM
2180
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $743K | ﹤0.01% |
19,162
-2,752
| -13% | -$107K |
|
2181
Aclaris Therapeutics
ACRS
$863M
| $734K | ﹤0.01% |
+29,120
| New | +$569K |
|
|
DVAX
2182
DELISTED
Dynavax Technologies
DVAX
| $733K | ﹤0.01% |
74,539
-24,466
| -25% | -$202K |
|
|
OPI
2183
DELISTED
Office Properties Income Trust
OPI
| $733K | ﹤0.01% |
26,620
+2,573
| +11% | +$66.7K |
|
|
CONN
2184
DELISTED
Conn's Inc.
CONN
| $729K | ﹤0.01% |
37,469
-15,373
| -29% | -$227K |
|
2185
Methode Electronics
MEI
$593M
| $728K | ﹤0.01% |
17,351
-175
| -1% | -$7.18K |
|
2186
Revolution Medicines
RVMD
$43.3B
| $728K | ﹤0.01% |
15,875
-76,945
| -83% | -$3.45M |
|
2187
Titan International
TWI
$438M
| $728K | ﹤0.01% |
78,450
-26,200
| -25% | -$205K |
|
2188
First Business Financial Services
FBIZ
$601M
| $726K | ﹤0.01% |
29,359
+48
| +0.2% | +$1.08K |
|
2189
Trupanion
TRUP
$1.36B
| $726K | ﹤0.01% |
9,528
-11,545
| -55% | -$1.18M |
|
|
DEN
2190
DELISTED
Denbury Inc.
DEN
| $723K | ﹤0.01% |
15,100
| – | – |
|
2191
Pitney Bowes
PBI
$2.28B
| $722K | ﹤0.01% |
87,613
-15,088
| -15% | -$129K |
|
2192
Sinclair Inc
SBGI
$1.03B
| $716K | ﹤0.01% |
24,477
-17,715
| -42% | -$589K |
|
2193
Peoples Bancorp
PEBO
$1.49B
| $714K | ﹤0.01% |
21,536
+3,387
| +19% | +$108K |
|
|
CXP
2194
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $713K | ﹤0.01% |
41,723
-75
| -0.2% | -$1.11K |
|
|
GPMT
2195
Granite Point Mortgage Trust
GPMT
$58.8M
| $712K | ﹤0.01% |
59,493
+28
| +0% | +$303 |
|
2196
Blink Charging
BLNK
$87.1M
| $711K | ﹤0.01% |
17,300
+3,100
| +22% | +$135K |
|
|
SFBS
2197
ServisFirst Bancshares
SFBS
$5B
| $711K | ﹤0.01% |
11,593
+3,406
| +42% | +$169K |
|
2198
Caleres
CAL
$461M
| $708K | ﹤0.01% |
32,459
+335
| +1% | +$5.71K |
|
2199
Griffon
GFF
$4.8B
| $707K | ﹤0.01% |
26,012
-5,880
| -18% | -$145K |
|
2200
The RMR Group
RMR
$346M
| $707K | ﹤0.01% |
17,325
-3,298
| -16% | -$130K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.